Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer

Gene

Volumn 511, Issue 2, 2012, Pages 169-176

  Lian, Yi Xin ^a   Chen, Rui ^a   Xu, Yue Hua ^a   Peng, Chun Lei ^a   Hu, Hua Cheng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

H1299 cell line; Lentivirus; Lung cancer; Protein tyrosine phosphatase 4A3; Small interfering RNA

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 4A3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN CELL CULTURE; IN VITRO STUDY; INHIBITION KINETICS; LENTIVIRINAE; LENTIVIRUS INFECTION; LUNG CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTEIN TYROSINE PHOSPHATASES; RNA, MESSENGER; RNA, SMALL INTERFERING;

LENTIVIRUS;

EID: 84868208073     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.079     Document Type: Article

References (31)

1. Alberg A.J., Brock M.V., Samet J.M. Epidemiology of lung cancer: looking to the future. J. Clin. Oncol. 2005, 23:3175-3185.
2. Basak S., et al. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol. Cell 2008, 30:303-314.
3. Brown M.S., Goldstein J.L. Protein prenylation. Mad bet for Rab. Nature 1993, 366:14-15.
4. Cai S.R., et al. Role of silencing phosphatase of regenerating liver-3 expression by microRNA interference in the growth of gastric cancer. Chin. Med. J. 2008, 121:2534-2538.
5. Cates C.A., et al. Prenylation of oncogenic human PTP (CAAX) protein tyrosine phosphatases. Cancer Lett. 1996, 110:49-55.
6. Daouti S., et al. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage. Cancer Res. 2008, 68:1162-1169.
7. Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell. Biol. 1994, 14:3752-3762.
8. Fiordalisi J.J., Keller P.J., Cox A.D. PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility. Cancer Res. 2006, 66:3153-3161.
9. Guo K., et al. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res. 2006, 66:9625-9635.
10. Guo K., et al. Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice. Oncotarget 2012, 3:158-167.
11. Hunter T. Signaling-2000 and beyond. Cell 2000, 100:113-127.
12. Hwang J.J., et al. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer. Oncol. Rep. 2012, 27:535-540.
13. Jiang Y., et al. Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis. Cancer Res. 2011, 71:234-244.
14. Kato H., Semba S., Miskad U.A., Seo Y., Kasuga M., Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin. Cancer Res. 2004, 10:7318-7328.
15. Kozlov G., Cheng J., Ziomek E., Banville D., Gehring K., Ekiel I. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J. Biol. Chem. 2004, 279:11882-11889.
16. Laurent C., Valet F., Planque N., Silveri L., Maacha S., Anezo O., Hupe P., Plancher C., Reyes C., Albaud B., Rapinat A., Gentien D., Couturier J., Sastre-Garau X., Desjardins L., Thiery J.P., Roman-Roman S., Asselain B., Barillot E., Pipemo-Neumann S., Saule S. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 2011, 71:666-674. [PubMed: 21135111].
17. Mao H., et al. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells. Gene 2011, 486:74-80.
18. Min S.H., Kim D.M., Heo Y.S., Kim H.M., Kim I.C., Yoo O.J. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Life Sci. 2010, 86:66-72.
19. Miskad U.A., Semba S., Kato H., Yokozaki H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004, 71:176-184.
20. Moores S.L., et al. Sequence dependence of protein isoprenylation. J. Biol. Chem. 1991, 266:14603-14610.
21. Ooki A., Yamashita K., Kikuchi S., Sakuramoto S., Katada N., Watanabe M. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:543-554.
22. Peng L., Jin G., Wang L., Guo J., Meng L., Shou C. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem. Biophys. Res. Commun. 2006, 342:179-183.
23. Polato F., et al. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin. Cancer Res. 2005, 11:6835-6839.
24. Rouleau C., et al. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol. Cancer Ther. 2006, 5:219-229. (PubMed: 16505094).
25. Saha S., et al. A phosphatase associated with metastasis of colorectal cancer. Science 2001, 294:1343-1346. (PubMed: 11598267).
26. Wang L., et al. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann. Oncol. 2006, 17:1517-1522.
27. Wang H., Quah S.Y., Dong J.M., Manser E., Tang J.P., Zeng Q. PRL-3 downregulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res. 2007, 67:2922-2926.
28. Wu X., et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am. J. Pathol. 2004, 164:2039-2054.
29. Yamashita S., et al. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. Ann. Thorac. Cardiovasc. Surg. 2007, 13:236-239.
30. Zeng Q., Si X., Horstmann H., Xu Y., Hong W., Pallen C.J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 2000, 275:21444-21452.
31. Zeng Q., Dong J.M., Guo K., Li J., Tan H.X., Koh V., Pallen C.J., Manser E., Hong W. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 2003, 63:2716-2722. [PubMed: 12782572].